Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1

Interferons (IFNs) are secreted cytokines with the ability to activate expression of IFN stimulated genes that increase resistance of cells to virus infections. Activated transcription factors in conjunction with chromatin remodelers induce epigenetic changes that reprogram IFN responses. Unexpected...

Full description

Bibliographic Details
Main Authors: Yaoyao Xue, Lang Pan, Spiros Vlahopoulos, Ke Wang, Xu Zheng, Zsolt Radak, Attila Bacsi, Lloyd Tanner, Allan R. Brasier, Xueqing Ba, Istvan Boldogh
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1161160/full
_version_ 1797754589115580416
author Yaoyao Xue
Yaoyao Xue
Lang Pan
Spiros Vlahopoulos
Ke Wang
Ke Wang
Xu Zheng
Xu Zheng
Zsolt Radak
Attila Bacsi
Lloyd Tanner
Allan R. Brasier
Xueqing Ba
Istvan Boldogh
author_facet Yaoyao Xue
Yaoyao Xue
Lang Pan
Spiros Vlahopoulos
Ke Wang
Ke Wang
Xu Zheng
Xu Zheng
Zsolt Radak
Attila Bacsi
Lloyd Tanner
Allan R. Brasier
Xueqing Ba
Istvan Boldogh
author_sort Yaoyao Xue
collection DOAJ
description Interferons (IFNs) are secreted cytokines with the ability to activate expression of IFN stimulated genes that increase resistance of cells to virus infections. Activated transcription factors in conjunction with chromatin remodelers induce epigenetic changes that reprogram IFN responses. Unexpectedly, 8-oxoguanine DNA glycosylase1 (Ogg1) knockout mice show enhanced stimuli-driven IFN expression that confers increased resistance to viral and bacterial infections and allergen challenges. Here, we tested the hypothesis that the DNA repair protein OGG1 recognizes 8-oxoguanine (8-oxoGua) in promoters modulating IFN expression. We found that functional inhibition, genetic ablation, and inactivation by post-translational modification of OGG1 significantly augment IFN-λ expression in epithelial cells infected by human respiratory syncytial virus (RSV). Mechanistically, OGG1 bound to 8-oxoGua in proximity to interferon response elements, which inhibits the IRF3/IRF7 and NF-κB/RelA DNA occupancy, while promoting the suppressor NF-κB1/p50-p50 homodimer binding to the IFN-λ2/3 promoter. In a mouse model of bronchiolitis induced by RSV infection, functional ablation of OGG1 by a small molecule inhibitor (TH5487) enhances IFN-λ production, decreases immunopathology, neutrophilia, and confers antiviral protection. These findings suggest that the ROS-generated epigenetic mark 8-oxoGua via its reader OGG1 serves as a homeostatic thresholding factor in IFN-λ expression. Pharmaceutical targeting of OGG1 activity may have clinical utility in modulating antiviral response.
first_indexed 2024-03-12T17:35:33Z
format Article
id doaj.art-672e0898900943f687352329b70e5da3
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-12T17:35:33Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-672e0898900943f687352329b70e5da32023-08-04T11:55:06ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-08-011410.3389/fimmu.2023.11611601161160Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1Yaoyao Xue0Yaoyao Xue1Lang Pan2Spiros Vlahopoulos3Ke Wang4Ke Wang5Xu Zheng6Xu Zheng7Zsolt Radak8Attila Bacsi9Lloyd Tanner10Allan R. Brasier11Xueqing Ba12Istvan Boldogh13Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United StatesKey Laboratory of Molecular Epigenetics of Ministry of Education, School of Life Science, Northeast Normal University, Changchun, ChinaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United StatesHoremeio Research Laboratory, First Department of Pediatrics, National and Kapodistrian, University of Athens, Athens, GreeceDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United StatesKey Laboratory of Molecular Epigenetics of Ministry of Education, School of Life Science, Northeast Normal University, Changchun, ChinaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United StatesKey Laboratory of Molecular Epigenetics of Ministry of Education, School of Life Science, Northeast Normal University, Changchun, ChinaResearch Institute of Molecular Exercise Science, University of Sport Science, Budapest, HungaryDepartment of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, HungaryRespiratory Medicine, Allergology & Palliative Medicine, Lund University and Skåne University Hospital, Lund, SwedenDepartment of Medicine, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United StatesKey Laboratory of Molecular Epigenetics of Ministry of Education, School of Life Science, Northeast Normal University, Changchun, ChinaDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United StatesInterferons (IFNs) are secreted cytokines with the ability to activate expression of IFN stimulated genes that increase resistance of cells to virus infections. Activated transcription factors in conjunction with chromatin remodelers induce epigenetic changes that reprogram IFN responses. Unexpectedly, 8-oxoguanine DNA glycosylase1 (Ogg1) knockout mice show enhanced stimuli-driven IFN expression that confers increased resistance to viral and bacterial infections and allergen challenges. Here, we tested the hypothesis that the DNA repair protein OGG1 recognizes 8-oxoguanine (8-oxoGua) in promoters modulating IFN expression. We found that functional inhibition, genetic ablation, and inactivation by post-translational modification of OGG1 significantly augment IFN-λ expression in epithelial cells infected by human respiratory syncytial virus (RSV). Mechanistically, OGG1 bound to 8-oxoGua in proximity to interferon response elements, which inhibits the IRF3/IRF7 and NF-κB/RelA DNA occupancy, while promoting the suppressor NF-κB1/p50-p50 homodimer binding to the IFN-λ2/3 promoter. In a mouse model of bronchiolitis induced by RSV infection, functional ablation of OGG1 by a small molecule inhibitor (TH5487) enhances IFN-λ production, decreases immunopathology, neutrophilia, and confers antiviral protection. These findings suggest that the ROS-generated epigenetic mark 8-oxoGua via its reader OGG1 serves as a homeostatic thresholding factor in IFN-λ expression. Pharmaceutical targeting of OGG1 activity may have clinical utility in modulating antiviral response.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1161160/fullROSNF-κBIRFIFN-λsmall airway epitheliuminnate immune response
spellingShingle Yaoyao Xue
Yaoyao Xue
Lang Pan
Spiros Vlahopoulos
Ke Wang
Ke Wang
Xu Zheng
Xu Zheng
Zsolt Radak
Attila Bacsi
Lloyd Tanner
Allan R. Brasier
Xueqing Ba
Istvan Boldogh
Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
Frontiers in Immunology
ROS
NF-κB
IRF
IFN-λ
small airway epithelium
innate immune response
title Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
title_full Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
title_fullStr Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
title_full_unstemmed Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
title_short Epigenetic control of type III interferon expression by 8-oxoguanine and its reader 8-oxoguanine DNA glycosylase1
title_sort epigenetic control of type iii interferon expression by 8 oxoguanine and its reader 8 oxoguanine dna glycosylase1
topic ROS
NF-κB
IRF
IFN-λ
small airway epithelium
innate immune response
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1161160/full
work_keys_str_mv AT yaoyaoxue epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT yaoyaoxue epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT langpan epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT spirosvlahopoulos epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT kewang epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT kewang epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT xuzheng epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT xuzheng epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT zsoltradak epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT attilabacsi epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT lloydtanner epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT allanrbrasier epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT xueqingba epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1
AT istvanboldogh epigeneticcontroloftypeiiiinterferonexpressionby8oxoguanineanditsreader8oxoguaninednaglycosylase1